Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up
With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards.
from NYT > Health https://ift.tt/2IpPvlz
via health&fitness
Aucun commentaire:
Enregistrer un commentaire